Overview

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Aldosterone blockade is useful in preserving residual renal function in patients on PD.The long term efficacy of dual blockade of the RAAS is better than monotherapy.
Phase:
N/A
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University
Collaborator:
Baxter Healthcare Corporation
Treatments:
Losartan
Spironolactone